We are live on ! Find out more
MFM

MHR Fund Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 119.57%
This Fund
S&P 500
This Quarter Est. Return
-4.26%
1 Year Est. Return
+119.57%
3 Year Est. Return
+332.02%
5 Year Est. Return
+163.28%
10 Year Est. Return
+516.96%
AUM
$586M
AUM Growth
+$53.7M
Cap. Flow
+$94.9M
Cap. Flow %
16.2%
Top 10 Hldgs %
99.73%
Holding
30
New
1
Increased
2
Reduced
Closed
12

Similar funds

MHR Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, MHR Fund Management held 30 positions worth $586M, up 10% from $532M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MHR Fund Management deployed $94.9M of net new capital in Q4 2022, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Iovance Biotherapeutics: 11,997,103 shares worth $76.7M.

By sector, the portfolio is most concentrated in Communication Services at 35% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the most notable exit was EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant, an estimated $990K sold.

  • MHR Fund Management's largest Q4 2022 buy was Iovance Biotherapeutics: 11,997,103 shares worth $76.7M.
  • MHR Fund Management added most to Lions Gate Entertainment Corp. Class A Voting Shares in Q4 2022, an estimated $6.16M increase.
  • MHR Fund Management fully exited EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q4 2022, selling an estimated $990K.
  • MHR Fund Management's ten largest holdings make up 100% of its $586M portfolio in Q4 2022.
  • MHR Fund Management opened 1 new position and closed 12 in Q4 2022.
  • MHR Fund Management's portfolio value rose 10% quarter-over-quarter to $586M.

Based on MHR Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.